Literature DB >> 17694179

Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure.

Hiroyuki Nakayama1, Xiongwen Chen, Christopher P Baines, Raisa Klevitsky, Xiaoying Zhang, Hongyu Zhang, Naser Jaleel, Balvin H L Chua, Timothy E Hewett, Jeffrey Robbins, Steven R Houser, Jeffery D Molkentin.   

Abstract

Loss of cardiac myocytes in heart failure is thought to occur largely through an apoptotic process. Here we show that heart failure can also be precipitated through myocyte necrosis associated with Ca2+ overload. Inducible transgenic mice with enhanced sarcolemmal L-type Ca2+ channel (LTCC) activity showed progressive myocyte necrosis that led to pump dysfunction and premature death, effects that were dramatically enhanced by acute stimulation of beta-adrenergic receptors. Enhanced Ca2+ influx-induced cellular necrosis and cardiomyopathy was prevented with either LTCC blockers or beta-adrenergic receptor antagonists, demonstrating a proximal relationship among beta-adrenergic receptor function, Ca2+ handling, and heart failure progression through necrotic cell loss. Mechanistically, loss of cyclophilin D, a regulator of the mitochondrial permeability transition pore that underpins necrosis, blocked Ca2+ influx-induced necrosis of myocytes, heart failure, and isoproterenol-induced premature death. In contrast, overexpression of the antiapoptotic factor Bcl-2 was ineffective in mitigating heart failure and death associated with excess Ca2+ influx and acute beta-adrenergic receptor stimulation. This paradigm of mitochondrial- and necrosis-dependent heart failure was also observed in other mouse models of disease, which supports the concept that heart failure is a pleiotropic disorder that involves not only apoptosis, but also necrotic loss of myocytes in association with dysregulated Ca2+ handling and beta-adrenergic receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17694179      PMCID: PMC1937500          DOI: 10.1172/JCI31060

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  76 in total

Review 1.  beta-adrenergic receptor blockade in chronic heart failure.

Authors:  M R Bristow
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

2.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

3.  Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release.

Authors:  Lars S Maier; Tong Zhang; Lu Chen; Jaime DeSantiago; Joan Heller Brown; Donald M Bers
Journal:  Circ Res       Date:  2003-04-03       Impact factor: 17.367

4.  The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.

Authors:  Tong Zhang; Lars S Maier; Nancy D Dalton; Shigeki Miyamoto; John Ross; Donald M Bers; Joan Heller Brown
Journal:  Circ Res       Date:  2003-04-03       Impact factor: 17.367

5.  Protein kinase A hyperphosphorylation increases basal current but decreases beta-adrenergic responsiveness of the sarcolemmal Na+-Ca2+ exchanger in failing pig myocytes.

Authors:  Shao-kui Wei; Abdul Ruknudin; Stephen U Hanlon; John M McCurley; Dan H Schulze; Mark C P Haigney
Journal:  Circ Res       Date:  2003-04-03       Impact factor: 17.367

Review 6.  Adrenergic overload and apoptosis in heart failure: implications for therapy.

Authors:  W S Colucci; D B Sawyer; K Singh; C Communal
Journal:  J Card Fail       Date:  2000-06       Impact factor: 5.712

7.  Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways.

Authors:  L J De Windt; H W Lim; S Haq; T Force; J D Molkentin
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

8.  Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology.

Authors:  Y Y Zhou; S Q Wang; W Z Zhu; A Chruscinski; B K Kobilka; B Ziman; S Wang; E G Lakatta; H Cheng; R P Xiao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-07       Impact factor: 4.733

9.  Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level.

Authors:  S B Liggett; N M Tepe; J N Lorenz; A M Canning; T D Jantz; S Mitarai; A Yatani; G W Dorn
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

10.  A mechanistic role for cardiac myocyte apoptosis in heart failure.

Authors:  Detlef Wencker; Madhulika Chandra; Khanh Nguyen; Wenfeng Miao; Stavros Garantziotis; Stephen M Factor; Jamshid Shirani; Robert C Armstrong; Richard N Kitsis
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

View more
  191 in total

1.  Low-intensity aerobic interval training attenuates pathological left ventricular remodeling and mitochondrial dysfunction in aortic-banded miniature swine.

Authors:  Craig A Emter; Christopher P Baines
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-03       Impact factor: 4.733

Review 2.  Mitochondria and heart failure: new insights into an energetic problem.

Authors:  L Chen; A A Knowlton
Journal:  Minerva Cardioangiol       Date:  2010-04       Impact factor: 1.347

3.  A caveolae-targeted L-type Ca²+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractility.

Authors:  Catherine A Makarewich; Robert N Correll; Hui Gao; Hongyu Zhang; Baohua Yang; Remus M Berretta; Victor Rizzo; Jeffery D Molkentin; Steven R Houser
Journal:  Circ Res       Date:  2012-02-02       Impact factor: 17.367

4.  Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways.

Authors:  Ethan J Anderson; Evelio Rodriguez; Curtis A Anderson; Kathleen Thayne; W Randolph Chitwood; Alan P Kypson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

5.  Genetic ablation of calcium-independent phospholipase A(2)γ (iPLA(2)γ) attenuates calcium-induced opening of the mitochondrial permeability transition pore and resultant cytochrome c release.

Authors:  Sung Ho Moon; Christopher M Jenkins; Michael A Kiebish; Harold F Sims; David J Mancuso; Richard W Gross
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

6.  Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice.

Authors:  John W Elrod; Renee Wong; Shikha Mishra; Ronald J Vagnozzi; Bhuvana Sakthievel; Sanjeewa A Goonasekera; Jason Karch; Scott Gabel; John Farber; Thomas Force; Joan Heller Brown; Elizabeth Murphy; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

Review 7.  The molecular composition of the mitochondrial permeability transition pore.

Authors:  Christopher P Baines
Journal:  J Mol Cell Cardiol       Date:  2009-02-20       Impact factor: 5.000

Review 8.  Cardiomyocyte Ca2+ homeostasis as a therapeutic target in heart failure with reduced and preserved ejection fraction.

Authors:  Deborah Peana; Timothy L Domeier
Journal:  Curr Opin Pharmacol       Date:  2017-04-22       Impact factor: 5.547

9.  Integrins protect cardiomyocytes from ischemia/reperfusion injury.

Authors:  Hideshi Okada; N Chin Lai; Yoshitaka Kawaraguchi; Peter Liao; Jeffrey Copps; Yasuo Sugano; Sunaho Okada-Maeda; Indroneal Banerjee; Jan M Schilling; Alexandre R Gingras; Elizabeth K Asfaw; Jorge Suarez; Seok-Min Kang; Guy A Perkins; Carol G Au; Sharon Israeli-Rosenberg; Ana Maria Manso; Zheng Liu; Derek J Milner; Stephen J Kaufman; Hemal H Patel; David M Roth; H Kirk Hammond; Susan S Taylor; Wolfgang H Dillmann; Joshua I Goldhaber; Robert S Ross
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

10.  Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury.

Authors:  Persoulla Nicolaou; Patricia Rodriguez; Xiaoping Ren; Xiaoyang Zhou; Jiang Qian; Sakthivel Sadayappan; Bryan Mitton; Anand Pathak; Jeffrey Robbins; Roger J Hajjar; Keith Jones; Evangelia G Kranias
Journal:  Circ Res       Date:  2009-03-19       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.